Thromboembolic events after endovascular treatment of unruptured intracranial aneurysms in two patients with antiphospholipid-antibody syndrome

Neuroradiology
L PierotM Dupuy

Abstract

Antiphospholipid antibodies (APAs) are circulating immunoglobulins associated with a hypercoagulable state. The antiphospholipid syndrome combines APAs and clinical manifestations, including arterial or venous thromboses and/or recurrent spontaneous fetal loss. The main risk incurred by endovascular treatment of intracranial aneurysms is the occurrence of thromboembolic events. We report two cases of patients with antiphospholipid syndrome who developed thromboembolic complications after the endovascular treatment of unruptured intracranial aneurysms.

Citations

Nov 28, 2014·Journal of Neurointerventional Surgery·Arturo ConsoliSalvatore Mangiafico
Feb 19, 2011·European Journal of Radiology·Ulrike I AttenbergerJohannes Rieger
May 10, 2008·Journal of Neuroradiology. Journal De Neuroradiologie·L Spelle, L Pierot
Sep 8, 2009·Neuroimaging Clinics of North America·Alexandra Borges
Oct 21, 2006·Neurosurgery·Richard J ParkinsonBernard R Bendok
Apr 5, 2008·Angiology·Yong-Song Guan, Ming-Quan Wang
Jan 14, 2012·AJNR. American Journal of Neuroradiology·H OishiH Arai
Sep 5, 2009·AJNR. American Journal of Neuroradiology·L PierotUNKNOWN ATENA investigators
Feb 23, 2018·Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences·Yon Kwon IhnIn Sup Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.